Explore Ergomed’s comprehensive whitepaper on Writing an IND Module 3 for Cell and Gene Therapy Products.
This essential guide dives into the complexities of Chemistry, Manufacturing, and Controls (CMC) requirements for cell and gene therapies, offering expert insights on regulatory hurdles, assay validation, cGMP adherence, and quality strategies. Ideal for biotech and pharma professionals, this resource provides practical strategies to streamline IND submissions and address the unique regulatory challenges of advanced therapies.
Maximize your regulatory approach with Ergomed’s expert guidance.